SPONSOR
Ruijin Hospital
Total Trials
19
Recruiting
19
Phases
Phase 2, Phase 1, Phase 2, Phase 1, EARLY_Phase 1, Phase 4, Phase 3
Conditions studied: SarcomaSarcoma,Soft TissueSarcoma of BonePeripheral T Cell LymphomaLymphoma, Mantle-CellParkinson Disease (PD)Colo-rectal CancerThird-line and Beyond TherapyTAS 102Bevacizumab
NCT06074692 Phase 2
Recruiting
PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)
Sarcoma
NCT05675813 Phase 1, Phase 2
Recruiting
Genotype-guided Treatment in Newly Diagnosed PTCL
Peripheral T Cell Lymphoma
NCT06136351 Phase 2
Recruiting
A Study of the Zanubrutinib Given in Combination With Bendamustine and Rituximab in (Elderly or TP53 Alterations or Chemotherapy Intolerance) Patients With Newly Diagnosed Mantle Cell Lymphoma
Lymphoma, Mantle-Cell
NCT07157345 Phase 1
Recruiting
Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's Disease
Parkinson Disease (PD)
NCT07085169 Phase 2
Recruiting
Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC
Colo-rectal Cancer
NCT07322718 EARLY_Phase 1
Recruiting
Safety and Efficacy Study of RXIM002 in Severe, Relapsed or Refractory Autoimmune Diseases
Relapsed/Refractory B Cell-Mediated Autoimmune Diseases
NCT06992661 Phase 1
Recruiting
A Study of the Pharmacokinetics and Safety of Single-dose Inhaled RJ026 in Healthy Volunteers and Patients With Interstitial Lung Disease
Interstitial Lung Disease (ILD)
NCT06793774
Recruiting
Risk Evaluation by COronary Imaging and Artificial intelliGence Based fuNctIonal analyZing tEchniques - III
Coronary Artery Disease
NCT04088422
Recruiting
Cell Free DNA in Mature B-cell Lymphoma
Mature B-Cell Lymphoma
NCT05806580 Phase 4
Recruiting
Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma
Relapsed or Refractory B-cell Lymphoma
NCT06400901
Recruiting
Analysis of Deep Brain Nuclei LFP and Cortical EEG Signals During the Recovery From General Anesthesia
Deep Brain Stimulation Surgery
NCT06269211 Phase 2
Recruiting
Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1 Positive Expression
Carcinoma, Non-Small-Cell Lung
NCT07366528 Phase 3
Recruiting
Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer
Gastric Cancer (GC)
NCT07272499 Phase 2
Recruiting
Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease
Mantle Cell Lymphoma (MCL)
NCT06577532 EARLY_Phase 1
Recruiting
Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors
Pancreatic Neoplasms
NCT05351346 Phase 3
Recruiting
Genotype-guided Treatment in DLBCL
Diffuse Large B Cell Lymphoma
NCT06458257
Recruiting
The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia
Acute Myeloid Leukemia
NCT06608160
Recruiting
68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.
PET / CT
NCT06718244 Phase 2
Recruiting
Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1
Acute Lymphoblastic Leukemia